Combination of avelumabwith peptide receptor radionuclide therapy (PRRT) or conventional fractionated radiotherapy (RT) in metastatic merkel cell carcinoma (mMCC) [GoTHAM study]
- Publication date
- 1 November 2019
- Publisher
- 'Royal College of Obstetricians & Gynaecologists (RCOG)'